β-blockers for infantile hemangiomas: A single-institution experience

Clinical Pediatrics

Volumn 50, Issue 8, 2011, Pages 757-763

  Blatt, Julie ^a   Morrell, Dean S ^a   Buck, Scott ^a   Zdanski, Carlton ^a   Gold, Stuart ^a   Stavas, Joseph ^a   Powell, Cynthia ^a   Burkhart, Craig N ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

hemangioma; propranolol; timolol

Indexed keywords

CORTICOSTEROID; PROPRANOLOL; THYROTROPIN; THYROXINE; TIMOLOL MALEATE;

ACROCYANOSIS; AROUSAL; ARTICLE; BRADYCARDIA; CAPILLARY HEMANGIOMA; CHILD; COUGHING; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG TREATMENT FAILURE; DRUG UTILIZATION; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY MONITORING; FEMALE; FREE THYROXINE INDEX; HUMAN; HYPOGLYCEMIA; HYPOTENSION; INFANT; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NEWBORN; PRESCHOOL CHILD; SEIZURE; SIDE EFFECT; SOMNOLENCE; THYROTROPIN BLOOD LEVEL; TOPICAL TREATMENT; UNSPECIFIED SIDE EFFECT;

ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; ADRENERGIC BETA-ANTAGONISTS; DRUG MONITORING; FEMALE; HEAD AND NECK NEOPLASMS; HEMANGIOMA; HUMANS; INFANT; LARYNGEAL NEOPLASMS; LIVER NEOPLASMS; MALE; PROPRANOLOL; RETROSPECTIVE STUDIES; TIMOLOL;

EID: 80052518387     PISSN: 00099228     EISSN: 19382707     Source Type: Journal    
DOI: 10.1177/0009922811405517     Document Type: Article

References (19)

1. Holland KE, Drolet BA Infantile hemangioma. Pediatr Clin North Am. 2010 ; 57: 1069-1083.
2. Frieden IJ, Eichenfield LF, Esterly NB, Geronemus R., Mallory SB Guidelines of care for hemangiomas of infancy: American Academy of Dermatology Guidelines/Outcomes Committee. J Am Acad Dermatol. 1997 ; 37: 631-637.
3. Leaute-Labreze C., Dumas de la Roque E., Hubiche T., Boralevi F., Thambo JB, Taïeb A. Propranolol for severe hemangiomas of infancy. N Engl J Med. 2008 ; 358: 2649-2651. (Pubitemid 351831393)
4. Holmes WJ, Mishra A., Gorst C., Liew SH Propranolol as first-line treatment for rapidly proliferating infantile haemangiomas. J Plast Reconstr Aesthet Surg. 2011 ; 64: 445-451.
5. Schiestl C., Neuhaus K., Zoller S., et al. Efficacy and safety of propranolol as first-line treatment for infantile hemangiomas. Eur J Pediatr. 2011 ; 170: 493-501.
6. Mazereeuw-Hautier J., Hoeger PH, Benlahrech S., et al. Efficacy of propranolol in hepatic infantile hemangiomas with diffuse neonatal hemangiomatosis. J Pediatr. 2010 ; 157: 340-342.
7. Pope E., Chakkittakandiyil A. Topical timolol gel for infantile hemangiomas: a pilot study. Arch Dermatol. 2010 ; 146: 564-565.
8. Patel S., Morrell DS, Blatt J., Calikoglu AS Severe hypothyroidism in an infant with a large cutaneous hemangioma. Paper presented at: Endocrine Society, 90th annual meeting; June 15-18, 2008 ; San Francisco, CA.
9. Kornasiewicz O., Debski M., Stepnowska M., Szałas A., Bar-Andziak E., Krawczyk M. The enzymatic activity of type 1 iodothyronine deiodinase (D1) is low in liver hemangioma: a preliminary study. Arch Immunol Ther Exp (Warsz). 2010 ; 58: 77-80.
10. Tsang MW, Stud M., Garzon MC, Frieden IJ How to measure a growing hemangioma and assess response to therapy. Pediatr Dermatol. 2006 ; 23: 187-190.
11. Buckmiller LM, Munson PD, Dyamenahalli U., et al. Propranolol for infantile hemangiomas: early experience at a tertiary vascular anomalies center. Laryngoscope. 2010 ; 120: 676-681.
12. Ostman-Smith I., Wettrell G., Riesenfeld T. A cohort study of childhood hypertrophic cardiomyopathy: improved survival following high-dose beta-adrenoceptor antagonist treatment. J Am Coll Cardiol. 1999 ; 34: 1813-1822.
13. Chavez H., Ozolins D., Losek JD Hypoglycemia and propranolol in pediatric behavioral disorders. Pediatrics. 1999 ; 103: 1290-1292. (Pubitemid 29258809)
14. Taketomo CK, Hodding JH, Kraus DM, eds. Pediatric Dosage Handbook. 9th ed. Hudson, OH: Lexi-Comp ; 2003.
15. Breur JM, de Graaf M., Breugem CC, Pasmans SG Hypoglycemia as a result of propranolol during treatment of infantile hemangioma: a case report [published online ahead of print August 4, 2010 ]. Pediatr Dermatol. doi: 10.1111/j.1525-1470.2010.01224.
16. Holland KE, Frieden IJ, Frommelt PC, Mancini AJ, Wyatt D., Drolet BA Characteristics of patients with propranolol toxicity. Arch Dermatol. 2010 ; 146: 775-778.
17. Fonseca VA Effects of beta-blockers on glucose and lipid metabolism. Curr Med Res Opin. 2010 ; 26: 615-629.
18. Rane A., Wilson JT Clinical pharmacokinetics in infants and children. Clin Pharmacokinet. 1976 ; 1: 1-24.
19. Munroe WP, Rindone JP, Kershner RM Systemic side effects associated with the ophthalmic administration of timolol. Drug Intell Clin Pharm. 1985 ; 19: 85-89. (Pubitemid 15160591)